No Picture
Trading Ideas

Coronavirus Drug Results Send Gilead Sciences Stock Flying; JPMorgan Weighs In

As the S&P 500 tumbled 15% over the past two months, shares of biotech Gilead Sciences (GILD) went in a somewhat different direction: Up 15%.And now it looks like Gilead is going up some more.New data from a University of Chicago Hospital Phase 3 clinical trial of Gilead’s remdesivir antiviral drug, also known as “GS-5734” shows promising results for the drug’s efficacy in treating the novel coronavirus. And no sooner had the data come out, than Gilead’s stock price began marching higher again, rising 12% in pre-market trading on Friday.So what did the data show, exactly?The study in question involved …read more […]

No Picture
Trading Ideas

Megvii IPO: Blacklisted Chinese Company Files with Hong Kong

In the summer of 2019, a Megvii IPO was filed with the Hong Kong Exchange. Investors thought they could expect Megvii stock soon after. However, those expectations were not met.
Megvii isn’t a public company yet. But investors shouldn’t worry. The Megvii IPO is on its way. Here’s what we know…
Megvii IPO: The Business

Yin Qi founded Megvii in 2011 with friends Tang Wenbin and Yang Mu. Qi is CEO of the Chinese technology company. It designs image recognition and deep-learning software. One of Megvii’s better known platforms is Face++ for facial recognition.
Megvii’s technology is used by governments and businesses. Some companies …read more […]

No Picture
Trading Ideas

Procter & Gamble Posts Earnings Beat, But Revenue Falls Short

Procter & Gamble (PG) has reported an earnings beat for the third quarter of fiscal year 2020 driven by strong organic sales figures. Third quarter Non-GAAP EPS of $1.17 beat the consensus estimate by $0.04.However, revenue of $17.21 billion (up 4.6% year-over-year) missed the Street’s expectations by $80 million. Shares are rising marginally higher in Friday’s pre-market trading.“Organic shipment volume increased six percent as strong consumer demand in North America and certain European markets due to the COVID-19 pandemic was partially offset by volume decreases in certain Asian markets due primarily to temporary disruption of consumer access to retail markets …read more […]

No Picture
Trading Ideas

Goldman predicts 36% drop in iPhone shipment, says time to sell Apple shares

The brokerage noted that average selling prices for consumer devices are likely to decline during a recession and remain weak well beyond the point when units recover. Earlier this week, Apple released a smaller iPhone priced at $399, lowering the starting price for the company’s smartphone line to broaden its appeal among budget-conscious customers. …read more […]